Cargando…

Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study

BACKGROUND: Genetic risk factors for chemotherapy-induced peripheral neuropathy (CIPN), a major dose-limiting side-effect of paclitaxel, are not well understood. METHODS: We performed a genome-wide association study (GWAS) in 183 paclitaxel-treated patients to identify genetic loci associated with C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hooshmand, Kosar, Goldstein, David, Timmins, Hannah C., Li, Tiffany, Harrison, Michelle, Friedlander, Michael L., Lewis, Craig R., Lees, Justin G., Moalem-Taylor, Gila, Guennewig, Boris, Park, Susanna B., Kwok, John B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724416/ https://www.ncbi.nlm.nih.gov/pubmed/36474270 http://dx.doi.org/10.1186/s12967-022-03754-4

Ejemplares similares

Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy
por: Makker, Preet G. S., et al.
Publicado: (2017)

Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
por: Park, Susanna B, et al.
Publicado: (2014)

Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease
por: Hooshmand, Kosar, et al.
Publicado: (2022)

Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy
por: Mizrahi, David, et al.
Publicado: (2021)

Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients
por: Mahfouz, Fawaz Mayez, et al.
Publicado: (2022)

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)
por: Chhibber, Aparna, et al.
Publicado: (2014)

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis
por: Theunissen, Frances, et al.
Publicado: (2021)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2014)

Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013)

Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
por: Lowy, Daniel B., et al.
Publicado: (2021)

A fruit fly model for studying paclitaxel-induced peripheral neuropathy and hyperalgesia
por: Hamoudi, Zina, et al.
Publicado: (2018)

Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2016)

The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
por: Sato, Junya, et al.
Publicado: (2016)

2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
por: Hertz, Daniel L., et al.
Publicado: (2018)

Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel
por: Chiang, Jeremy Chung Bo, et al.
Publicado: (2021)

Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy
por: Cirrincione, Anthony M., et al.
Publicado: (2022)

Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)

Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury
por: Perera, Chamini J, et al.
Publicado: (2015)

Oxaliplatin-induced haematological toxicity and splenomegaly in mice
por: Lees, Justin G., et al.
Publicado: (2020)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Effect of certain trimethoxy flavones on paclitaxel - induced peripheral neuropathy in mice
por: Nadipelly, Jagan, et al.
Publicado: (2018)

Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
por: Ghoreishi, Zohreh, et al.
Publicado: (2018)

Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2017)

Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel‐induced peripheral neuropathy
por: Kalynovska, Nataliia, et al.
Publicado: (2020)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
por: Caillaud, Martial, et al.
Publicado: (2020)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2022)

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
por: Chen, Ciao-Sin, et al.
Publicado: (2023)

Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
por: Li, Tiffany, et al.
Publicado: (2022)

Acupuncture for Paclitaxel-Induced Peripheral Neuropathy: A Review of Clinical and Basic Studies
por: Zhao, Yu-Xue, et al.
Publicado: (2021)

Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis
por: Duffy, Samuel S., et al.
Publicado: (2019)

Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
por: Burgess, B. L., et al.
Publicado: (2022)

Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy
por: Griffiths, Lisa A., et al.
Publicado: (2015)

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
por: LoCoco, Peter M, et al.
Publicado: (2017)

Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
por: Brazill, Jennifer M., et al.
Publicado: (2018)

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors
por: Miaskowski, Christine, et al.
Publicado: (2019)

A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy
por: Leen, Alisha Joan, et al.
Publicado: (2022)

New Treatment for the Cognitive and Emotional Deficits Linked with Paclitaxel-Induced Peripheral Neuropathy in Mice
por: Martínez-Martel, Ignacio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2lloi76462vh7t7skj4qbsb2v